Form D · Biotechnology
Canopy Biosciences, LLC
Saint Louis, MO · CIK 0001712948
Offering snapshot reported Jan 3, 2018 · SEC filing
- Reported sold
- $2.08M Offering amount: $3.4M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Dec 20, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2018 | Initial | $2,075,000 | No comparison | 16 | SEC filing |
| Jul 31, 2017 | Initial | $1,125,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-302234
Source: Form D, filed Jan 3, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Bolten | Director |
| David Kingsley | Director |
| David Smoller | Director |
| Edward Weinstein | Director, Executive |
| Crystal Winkeler | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4320 Forest Park Avenue Suite 303
Saint Louis, MO, 63108
Saint Louis, MO, 63108